National Chapter Vision Webinar: Update on Emerging Therapies

The webinar provided reviews of several treatments in the clinical development pipeline including AGTC's gene therapy clinical trials for X-linked retinitis pigmentosa and achromatopsia; SparingVision's emerging cone-saving and cone-restoring treatments for retinitis pigmentosa, Usher syndrome, and related conditions; gene-agnostic approaches for a variety of conditions, clinical trials underway for Stargardt disease, and new emerging gene therapies for Leber congenital amaurosis.

Presenters included: 

Daniel Chung, DO, Chief Medical Officer, SparingVision
Bright Ashimatey, OD, PhD, FAAO, Clinical Research Scientist, AGTC
Claire Gelfman, PhD, Chief Scientific Officer, Foundation Fighting Blindness
Ben Shaberman, Senior Director, Scientific Outreach, Foundation Fighting Blindness

[hanialborati]

Thank you everyone for the great job I wish you all the best a lot of people are waiting for all your success and hope for a lot of families again thank you very much.

[-kr]

Thank you Ben and all participants i appreciate your work

[toddm]

Excellent update! Knowing that so much work is underway in this field is very encouraging. Please keep up the inspired efforts to solve the myriad challenges of understanding the retina and addressing the many variations of problems.

[tsaonedintle]

I have IRD i do not the specific one but i am hopeful i hope we could be included here in Africa

[BKproduction]

i hope the scinese / research on eyes improve quickly ...
i am 27 years old with RP and i did my genetic test my resault came back with Pcare
gene mutation Q_Q i hope there is something in the future that can help me and can help all patients With RP